Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine (OASIS(EM))

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03836040
Recruitment Status : Recruiting
First Posted : February 11, 2019
Last Update Posted : May 19, 2022
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 17, 2026
Estimated Study Completion Date : July 29, 2027